CoChat

Sclerostin antibody treatment enhances bone strength but does not prevent growth retardation in young mice treated with dexamethasone

Marenzana, M., Greenslade, K., Eddleston, A., Okoye, R., Marshall, D., Moore, A., Robinson, M. K. · 2011 · Arthritis & Rheumatism
Cited by 73

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Objective: Exposure to supraphysiologic levels of glucocorticoid drugs is known to have detrimental effects on bone formation and linear growth. Patients with sclerosteosis lack the bone regulatory protein sclerostin, have excessive bone formation, and are typically above average in height. This study was undertaken to characterize the effects of a monoclonal antibody to sclerostin (Scl‐AbI) in mice exposed to dexamethasone (DEX). Methods: Young mice were concomitantly treated with DEX (or vehicle control) and Scl‐AbI antibody (or isotype‐matched control antibody [Ctrl‐Ab]) in 2 independent studies. Linear growth, the volume and strength of the bones, and the levels of bone turnover markers were analyzed. Results: In DEX‐treated mice, Scl‐AbI had no significant effect on linear growth when compared to control treatment (Ctrl‐Ab). However, in mice treated with DEX and Scl‐ABI, a significant increase in trabecular bone at the femoral metaphysis (bone volume/total volume +117% versus Ctrl‐Ab–treated mice) and in the width and volume of the cortical bone at the femoral diaphysis (+24% and +20%, respectively, versus Ctrl‐Ab–treated mice) was noted. Scl‐AbI treatment also improved mechanical strength (as assessed by 4‐point bending studies) at the femoral diaphysis in DEX‐treated mice (maximum load +60% and ultimate strength +47% in Scl‐AbI–treated mice versus Ctrl‐Ab–treated mice). Elevated osteocalcin levels were not detected in DEX‐treated mice that received Scl‐AbI, although levels of type 5b tartrate‐resistant acid phosphatase were significantly lower than those observed in mice receiving DEX and Ctrl‐Ab. Conclusion: Scl‐AbI treatment does not prevent the detrimental effects of DEX on linear growth, but the antibody does increase both cortical and trabecular bone and improves bone mechanical properties in DEX‐treated mice.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.30385

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

Metadata

Authors
Marenzana, M., Greenslade, K., Eddleston, A., Okoye, R., Marshall, D., Moore, A., & Robinson, M. K.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2011-08
Volume
63
Issue
8
Pages
2385-2395
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2057472181
Cited by
73
References
8
FWCI
8.56
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.